Literature DB >> 34163552

Diffuse Cerebral Edema After Moyamoya Disease-Related Intracerebral Hemorrhage: A Case Report.

Alvin S Das1,2, Robert W Regenhardt2, Nirav Patel3, Steven K Feske1, Matthew B Bevers1, Henrikas Vaitkevicius1, Saef Izzy1.   

Abstract

Moyamoya disease (MMD) is a rare, progressive occlusive disease characterized by bilateral internal carotid artery hypoplasia that often presents with ischemic stroke and intracerebral hemorrhage (ICH). Although MMD-related ICH is generally managed similarly to spontaneous ICH, we present a case in which standard management strategies may have led to an unprecedented devastating outcome. A 37-year-old female without any previous medical history presented with headache and right-sided weakness. A computed tomography (CT) scan revealed a large left basal ganglia ICH. Vessel imaging revealed diffuse narrowing of the entire anterior circulation with prominent leptomeningeal collaterals consistent with MMD. The patient's systolic blood pressure was kept under 140 mmHg. During the hospitalization, she became hypocarbic while being trialed on pressure support ventilation. Several hours later, she developed fixed and dilated pupils. Repeat CT head showed new diffuse cerebral edema with tonsillar herniation. Despite hyperosmolar therapy, paralytics, pentobarbital, and cerebrospinal fluid diversion, no improvement was noted. Unfortunately, brain MRI revealed multifocal brainstem infarcts with superimposed Duret hemorrhages. Herein, we report diffuse cerebral edema as a complication of MMD-related ICH. We hypothesize that disruptions of delicate cerebral autoregulatory mechanisms led to extensive hypoxic-ischemic injury. In the setting of ICH, aggressive blood pressure management coupled with relative hypocapnia may have likely caused vasoconstriction of poorly compliant arteries leading to worsened cerebral blood flow and ischemia. Therefore, because of its complex pathophysiology, strict adherence to eucapnia should be maintained in MMD-related ICH.
© The Author(s) 2020.

Entities:  

Keywords:  case report; cerebral edema; intracerebral hemorrhage; moyamoya disease

Year:  2020        PMID: 34163552      PMCID: PMC8182400          DOI: 10.1177/1941874420980611

Source DB:  PubMed          Journal:  Neurohospitalist        ISSN: 1941-8744


  11 in total

Review 1.  Moyamoya disease: current concepts and future perspectives.

Authors:  Satoshi Kuroda; Kiyohiro Houkin
Journal:  Lancet Neurol       Date:  2008-11       Impact factor: 44.182

2.  Impaired dynamic cerebral autoregulation in moyamoya disease.

Authors:  Jie Chen; Jia Liu; Lian Duan; Ren Xu; Yi-Qin Han; Wei-Hai Xu; Li-Ying Cui; Shan Gao
Journal:  CNS Neurosci Ther       Date:  2013-06-03       Impact factor: 5.243

3.  Guidelines for the Management of Spontaneous Intracerebral Hemorrhage: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association.

Authors:  J Claude Hemphill; Steven M Greenberg; Craig S Anderson; Kyra Becker; Bernard R Bendok; Mary Cushman; Gordon L Fung; Joshua N Goldstein; R Loch Macdonald; Pamela H Mitchell; Phillip A Scott; Magdy H Selim; Daniel Woo
Journal:  Stroke       Date:  2015-05-28       Impact factor: 7.914

4.  Moyamoya disease-related versus primary intracerebral hemorrhage: [corrected] location and outcomes are different.

Authors:  Hyun-Wook Nah; Sun U Kwon; Dong-Wha Kang; Jae-Sung Ahn; Byung-Duk Kwun; Jong S Kim
Journal:  Stroke       Date:  2012-06-12       Impact factor: 7.914

5.  Hematoma volume is a predictive factor of disturbed autoregulation after spontaneous intracerebral hemorrhage.

Authors:  Hongyin Ma; Zhen-Ni Guo; Xin Sun; Jia Liu; Shan Lv; Lu Zhao; Weitong Guo; Hang Jin; Yi Yang
Journal:  J Neurol Sci       Date:  2017-09-28       Impact factor: 3.181

6.  Preoperative and postoperative evaluation of cerebral perfusion and vasodilatory capacity with 99mTc-HMPAO SPECT and acetazolamide in childhood Moyamoya disease.

Authors:  H Touho; J Karasawa; H Ohnishi
Journal:  Stroke       Date:  1996-02       Impact factor: 7.914

7.  Diffuse leptomeningeal enhancement, "ivy sign," in magnetic resonance images of moyamoya disease in childhood: case report.

Authors:  T Ohta; H Tanaka; T Kuroiwa
Journal:  Neurosurgery       Date:  1995-11       Impact factor: 4.654

8.  Acute cerebral ischemia following intraventricular hemorrhage in moyamoya disease: early perfusion computed tomography findings.

Authors:  I-Chang Su; Chi-Cheng Yang; Wei-Han Wang; Jing-Er Lee; Yong-Kwang Tu; Kuo-Chuan Wang
Journal:  J Neurosurg       Date:  2008-12       Impact factor: 5.115

Review 9.  Moyamoya disease and syndromes: from genetics to clinical management.

Authors:  Stéphanie Guey; Elisabeth Tournier-Lasserve; Dominique Hervé; Manoelle Kossorotoff
Journal:  Appl Clin Genet       Date:  2015-02-16

Review 10.  Moyamoya Disease: Epidemiology, Clinical Features, and Diagnosis.

Authors:  Jong S Kim
Journal:  J Stroke       Date:  2016-01-29       Impact factor: 6.967

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.